Associazione Italiana per la Lotta al Neuroblastoma
Associazione Italiana per la Lotta al Neuroblastoma is a 1993-founded Italian nonprofit (ETS) that funds research against neuroblastoma and pediatric solid tumors through donations, seasonal campaigns, the ANB Store, and the 5x1000 tax program, supporting hospitals and universities across Italy.
- Company typePrivate
- Founded1993
- HeadquartersGenova, Italy
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Associazione Italiana per la Lotta al Neuroblastoma does
Associazione Italiana per la Lotta al Neuroblastoma is an Italian non-profit organization (ETS - Ente del Terzo Settore) founded on July 23, 1993 at the Istituto Giannina Gaslini pediatric hospital in Genova, dedicated to funding research against neuroblastoma and other pediatric solid tumors. It was established by parents who had experienced their children's illness and by oncologists seeking better therapeutic outcomes; founding member Sara Costa has served as president since 1996. The association operates with a small core team of 13 employees and an annual fundraising target in the low single-digit million euros, with €1.2M raised in the first 10 months of 2024 and €2M of project value committed for 2024-2025.
Its core "products" are solidarity fundraising mechanisms rather than technology: the ANB Store e-commerce platform selling bomboniere, Easter eggs, Christmas panettoni, scarves, and personalized certificates priced from €2 to €12; recurring seasonal campaigns such as "Cerco un uovo amico" (Easter) and "Dono Ricerca. RiDono la vita" (Christmas); the 5x1000 Italian tax-designation program; and corporate partnership programs. The association's scientific arm, the Fondazione Italiana per la Lotta al Neuroblastoma (established 1998), selects and funds approved research projects across a network of Italian hospitals and universities (CEINGE Napoli, Università di Bologna, Università La Sapienza Roma, Università di Trento-CIBIO, Istituto di Ricerca Pediatrica Città della Speranza Padova) and international collaborators in the UK, Canada, Spain, Germany, and Australia.
Revenue is generated entirely through donations, charity campaigns, the ANB Store, and the 5x1000 tax program. The go-to-market is community-led: grassroots fundraising, volunteer networks, corporate CSR partnerships, and direct public engagement. The strategic plan 2024-2028 anchors current research investments in the VAMOLAA project (MYCN gene inhibition, launched January 2025 with 8 research groups) and the AlterAction project (CRISPR/Cas9 and third-generation sequencing, launched November 2025), alongside CAR-T cell therapy research at Ospedale Bambino Gesù. The association is recognized by the Italian State (D.M. 26/04/1994), registered in RUNTS (Rep. N° 161061), and holds the IID "Donare con fiducia" certification.
Associazione Italiana per la Lotta al Neuroblastoma firmographics
Firmographics- Name
- Associazione Italiana per la Lotta al Neuroblastoma
- Legal name
- Associazione Italiana per la Lotta al Neuroblastoma ETS
- Website
- https://neuroblastoma.org
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Associazione Italiana per la Lotta al Neuroblastoma is a 1993-founded Italian nonprofit (ETS) that funds research against neuroblastoma and pediatric solid tumors through donations, seasonal campaigns, the ANB Store, and the 5x1000 tax program, supporting hospitals and universities across Italy.
- Ownership category
- akta.pro rank
Associazione Italiana per la Lotta al Neuroblastoma industry classification
Industry- Product category
- Pediatric Cancer Research Nonprofit
- NAICS
- Voluntary Health Organizations (813212), Grantmaking and Giving Services (8132)
- SIC
- Services-Social Services (8300)
- akta.pro industry
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
Keywords
Where Associazione Italiana per la Lotta al Neuroblastoma is headquartered
LocationHeadquarters
- HQ city
- Genova
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
Associazione Italiana per la Lotta al Neuroblastoma business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Donations and Charitable Contributions: Primary revenue stream from individual donors, corporate sponsors, and supporters. Donations are collected through the website, direct appeals, and campaign-specific initiatives. Includes 5x1000 tax designation (Italian tax contribution mechanism).
- ANB Store Sales: Solidarity store selling symbolic gifts including chocolate eggs, panettoni, personalized certificates, and other merchandise. Proceeds support research projects.
- Campaign Fundraising: Seasonal campaigns (Easter 'Cerco un uovo amico', Christmas 'Dono Ricerca. RiDono la vita') that mobilize supporters through events, corporate partnerships, and direct appeals.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | — | Solidarity products (BIS VASCHETTE SOLIDALI) priced at €12.00 |
| Unit Pricing | — | Solidarity bomboniere starting at €7.00 |
| Unit Pricing | — | Solidarity certificates (PERGAMENA SOLIDALE) at €2.00 |
| Other | — | Voluntary donations - variable amounts |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Associazione Italiana per la Lotta al Neuroblastoma product offering
Product offeringCore offering
The Associazione Italiana per la Lotta al Neuroblastoma is an Italian non-profit (ETS) that funds pediatric neuroblastoma and solid tumor research through individual donations, corporate partnerships, the 5x1000 tax mechanism, and proceeds from the ANB STORE online solidarity gift shop. It operates an affiliated scientific foundation (Fondazione Italiana per la Lotta al Neuroblastoma, est. 1998) that selects and funds approved research projects at Italian and international institutions, and it runs annual Easter ('Cerco un uovo amico') and Christmas ('Dono Ricerca. RiDono la vita') campaigns.
Product overview
Associazione Italiana per la Lotta al Neuroblastoma operates primarily as a charitable foundation and research funding organization, not a technology company. Its main offerings include: (1) the ANB STORE e-commerce platform selling solidarity gifts (bomboniere, Easter eggs, Christmas panettoni, scarves, books) to fund research; (2) annual fundraising campaigns including 'Cerco un uovo amico' (Easter), 'Dono Ricerca. RiDono la vita' (Christmas), and 5x1000 tax donation campaigns; and (3) the Fondazione Italiana per la Lotta al Neuroblastoma scientific arm which selects and funds approved research projects. The association's key research initiatives include the VAMOLAA multicentric project targeting MYCN gene inhibition and the AlterAction project using third-generation DNA/RNA sequencing and CRISPR/Cas9 technology.
Differentiator
Problem solved
Functional benefit
Products and services
- ANB STORE Online e-commerce platform selling solidarity gifts (bomboniere, chocolate eggs, holiday items, certificates, books) where proceeds fund neuroblastoma and pediatric solid tumor research. For Italian individual donors, families, and corporate partners.
- BIS VASETTI SOLIDALI Solidarity jars priced at €12.00, sold through the ANB Store to fund research; part of the gift collection supporting neuroblastoma research.
- BOMBONIERA SOLIDALE IN CARTA SEMI Paper seed bomboniera priced at €7.00, a commemorative solidarity gift sold to fund research; typically used for weddings and other personal occasions.
- PERGAMENA SOLIDALE Customizable solidarity parchment certificate priced at €2.00, a commemorative document sold to support research and personalize acknowledgments for donations or special occasions.
- BOMBONIERA SOLIDALE CON NASTRINO Solidarity bomboniera with ribbon priced at €5.00, available in multiple variants for different occasions. Sold through the ANB Store to fund research.
- Campagna 'Cerco un uovo amico' Annual Easter campaign selling solidarity chocolate eggs through the ANB Store to fund the VAMOLAA research project targeting the MYCN gene in neuroblastoma.
- Campagna 'Per il tuo magico Natale' Christmas campaign selling panettoni, pandori and holiday solidarity gifts through the ANB Store to fund the AlterAction project and other research projects.
- 5x1000 Donation Campaign Italian tax donation channel allowing Italian taxpayers to direct 5x1000 (0.5%) of their IRPEF tax liability to support the association's neuroblastoma research funding.
- Fondazione Italiana per la Lotta al Neuroblastoma Scientific foundation affiliated with the association, responsible for evaluating and funding approved neuroblastoma and pediatric solid tumor research projects carried out at Italian and international institutions.
- Foulard Mon Trésor Silk scarf from AERIAL COSTUME's LIAISON collection, designed by illustrator Aldo Sacchetti, with a portion of proceeds supporting ANB research as part of a Valentine's Day solidarity initiative.
Quantifiable outcome
- €1.2 million raised in first 10 months of 2024
- +2 more outcomes
Companies that use Associazione Italiana per la Lotta al Neuroblastoma
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
Associazione Italiana per la Lotta al Neuroblastoma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Associazione Italiana per la Lotta al Neuroblastoma partnerships and signals
Strategic signalPartnerships
20 partnerships are on record, tiered core, major and minor.
- OPEN (Oncologia Pediatrica e Neuroblastoma Odv)coreCo-promoter of the VAMOLAA project alongside Fondazione Italiana per la Lotta al Neuroblastoma. Represents pediatric oncology and neuroblastoma patient advocacy.
- Fondazione Italiana per la Lotta al NeuroblastomacoreScientific arm of the association established in 1998 with headquarters at Istituto Gaslini. Responsible for selecting and funding approved research projects. Operates with separate governance but intimately connected to the association.
- CEINGE-Biotecnologie Avanzate di NapolicoreResearch center coordinating AlterAction project and VAMOLAA. Led by Professor Mario Capasso, conducts genetic research on neuroblastoma.
- Università di Trento-CIBIOcoreCo-coordinator of AlterAction project with Professor Alessandro Quattrone as lead researcher.
- Università di BolognacoreResearch partner in VAMOLAA project. Professor Roberto Tonelli leads work on MYCN gene inhibition using BGA002 molecule developed by Biogenera.
- Università La Sapienza di RomacoreResearch partner in VAMOLAA project with researchers Alessandro Paiardini and Giuseppe Giannini involved.
- Brunel University London / Università di ChietimajorInternational research partner in VAMOLAA project with Arturo Sala as lead researcher.
- Istituto di Ricerca Pediatrica Città della Speranza di PadovacoreResearch partner in AlterAction project with researcher Sanja Aveic.
- AERIAL COSTUMEminorFashion company collaborating on the Mon Trésor solidarity scarf project. Part of LIAISON project linking fashion design with charitable causes.
- Aldo Sacchetti (Fashion Illustrator)minorFashion illustrator collaborating with AERIAL COSTUME on the Mon Trésor scarf supporting the association.
- University of British Columbia (Canada)majorInternational collaborator in VAMOLAA project with Pieter Cullis as contact.
- Cambridge University (UK)majorInternational collaborator in VAMOLAA project with Laura Itzhaki as contact.
- Vall d'Hebron Institute of Oncology, BarcelonamajorInternational collaborator in VAMOLAA project with Laura Soucek as contact.
- Deutsches Krebsforschungszentrum, HeidelbergmajorInternational collaborator in VAMOLAA project with Frank Westermann as contact.
- Children's Cancer Institute Australia, SydneymajorInternational collaborator in VAMOLAA project with Michelle Haber as contact.
- Biogenera SpAcorePharmaceutical biotechnology company developing BGA002 molecule for MYCN gene inhibition in neuroblastoma treatment.
- Ospedale Pediatrico Bambino Gesù di RomacoreLeading pediatric hospital conducting CAR-T cell therapy research for neuroblastoma. Study supported by the foundation published in New England Journal of Medicine.
- Ediltur s.r.l.minorCompany that organized donation of solidarity Easter eggs to Bari pediatric hospital. Example of corporate social responsibility partnership.
- Associazione BerardiminorMilitary association that distributes solidarity Easter eggs to children in Avellino region. Partners with local institutions.
- Associazione Polizia Locale d'Italia (A-PL)minorLocal police association providing moral patronage for 'Cerco un uovo amico' Easter campaign.
Scale indicators4 records
Recent moves7 records
Expansion highlights10 records
Associazione Italiana per la Lotta al Neuroblastoma competitors and assessment
Company assessmentBroad incumbents
- AIRC - Fondazione AIRC per la ricerca sul cancro: Italy's largest cancer research nonprofit, funding peer-reviewed oncology research across all cancer types. Comparable as an Italian nonprofit that channels donations into research grants and runs an analogous 5x1000 + donation + branded-products fundraising model, but operates at vastly greater scale across all cancer types rather than specializing in neuroblastoma.
- Cancer Research UK: The UK's largest cancer research charity. Comparable as a donation-funded research grantmaker with retail and volunteer fundraising channels, but covers all cancer types at a multibillion-pound scale versus ANB's narrow neuroblastoma focus. ANB collaborates with Cambridge researchers who are also funded by CRUK.
- St. Jude Children's Research Hospital / ALSAC: The largest U.S. pediatric cancer research and treatment nonprofit. Comparable mission (funding pediatric oncology research, family support) and analogous donation + retail (ALSAC) + cause-marketing revenue model, but at far greater scale and with in-house research operations versus ANB's grantmaking-only model.
Others
- Fondazione Italiana per la Lotta al Neuroblastoma: ANB's own scientific arm, established in 1998 to select and fund approved research projects. Not a competitor but a structurally related entity sharing the same registered address at Gaslini Institute — included because it is the most directly comparable governance and research-grantmaking vehicle, and often co-funds with international foundations.
Direct peers
- Solving Kids' Cancer: U.S./UK charity focused on childhood cancer research funding with an emphasis on hard-to-treat pediatric cancers including neuroblastoma. Direct comparable as a disease-focused pediatric cancer research funder with similar grantmaking model.
- Rally Foundation for Childhood Cancer Research: U.S. nonprofit funding childhood cancer research through community-led events and grassroots fundraising. Closely analogous operating model (volunteer-driven, community events, research grants) and similar scale profile, illustrating the typical operational template ANB follows.
- National Pediatric Cancer Foundation: U.S. nonprofit dedicated to pediatric cancer research funding and clinical trial collaboration. Comparable mission focus, donor-funded grantmaking model, and research network approach, though operating primarily in the U.S. pediatric oncology ecosystem.
- Fondazione Telethon: Italian nonprofit that funds rare-disease research through donations and televised campaigns. Highly comparable operating model (community-led fundraising, donor-funded research grants, Italian 5x1000 channel) and similar scale, though Telethon covers a broader portfolio of rare genetic diseases rather than a single pediatric oncology indication.
- Children's Cancer Research Fund (CCRF): U.S. nonprofit funding children's cancer research through donations and community fundraising. Direct comparable on mission (pediatric cancer research grantmaking) and operating model (community-led events, donor-driven funding).
- Alex's Lemonade Stand Foundation: U.S. nonprofit dedicated exclusively to childhood cancer research funding. Closely comparable mission focus (pediatric cancer research grantmaking) and community-led fundraising approach, but operates at substantially larger scale in the U.S. donor market.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Associazione Italiana per la Lotta al Neuroblastoma social profiles
Digital presenceAssociazione Italiana per la Lotta al Neuroblastoma compliance and trust
Trust signalCompliance4 records
Associazione Italiana per la Lotta al Neuroblastoma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Associazione Italiana per la Lotta al Neuroblastoma leadership team
Management profileNumber of profiles
Profiles2 records
Associazione Italiana per la Lotta al Neuroblastoma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Associazione Italiana per la Lotta al Neuroblastoma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Associazione Italiana per la Lotta al Neuroblastoma
What does Associazione Italiana per la Lotta al Neuroblastoma do?
The Associazione Italiana per la Lotta al Neuroblastoma is an Italian non-profit (ETS) that funds pediatric neuroblastoma and solid tumor research through individual donations, corporate partnerships, the 5x1000 tax mechanism, and proceeds from the ANB STORE online solidarity gift shop. It operates an affiliated scientific foundation (Fondazione Italiana per la Lotta al Neuroblastoma, est. 1998) that selects and funds approved research projects at Italian and international institutions, and it runs annual Easter ('Cerco un uovo amico') and Christmas ('Dono Ricerca. RiDono la vita') campaigns.
Is Associazione Italiana per la Lotta al Neuroblastoma a public or private company?
Associazione Italiana per la Lotta al Neuroblastoma is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Associazione Italiana per la Lotta al Neuroblastoma founded?
Associazione Italiana per la Lotta al Neuroblastoma was founded in 1993. It employs 11 to 50 people.
Where is Associazione Italiana per la Lotta al Neuroblastoma based?
Associazione Italiana per la Lotta al Neuroblastoma is headquartered in Genova, Italy, in the Europe region.
How does Associazione Italiana per la Lotta al Neuroblastoma make money?
Three revenue lines are on record. Donations and Charitable Contributions are the primary driver. The others are ANB Store Sales and campaign Fundraising.
Who are Associazione Italiana per la Lotta al Neuroblastoma's main competitors?
Broad incumbents on record are AIRC - Fondazione AIRC per la ricerca sul cancro, Cancer Research UK and St. Jude Children's Research Hospital / ALSAC. Fondazione Italiana per la Lotta al Neuroblastoma is listed as an others. Direct peers are Solving Kids' Cancer, Rally Foundation for Childhood Cancer Research, National Pediatric Cancer Foundation, Fondazione Telethon, Children's Cancer Research Fund (CCRF) and Alex's Lemonade Stand Foundation.
Does Associazione Italiana per la Lotta al Neuroblastoma have an API?
No public API is recorded for Associazione Italiana per la Lotta al Neuroblastoma.
What industry is Associazione Italiana per la Lotta al Neuroblastoma in?
Associazione Italiana per la Lotta al Neuroblastoma's product category is Pediatric Cancer Research Nonprofit. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 813212 and its SIC code is 8300.